Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ
Journal of Drugs in Dermatology · 2026-05-01 · 25 (5) · 454-459
DOI: 10.36849/jdd.9192 ↗At a glance
Klinische Studie in Journal of Drugs in Dermatology, published online on 2026-04-01. Written by Mark S Nestor and 3 co-authors. Major MEDLINE topics: Aminolevulinic Acid, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, Facial Neoplasms.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Substances
Cite
APA
Nestor, M. S., Chaudry, A., Vanaria, R. J., & Bhupalam, V. (2026). Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ. Journal of Drugs in Dermatology, 25(5), 454-459. https://doi.org/10.36849/jdd.9192
Vancouver
Nestor MS, Chaudry A, Vanaria RJ, Bhupalam V. Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ. Journal of Drugs in Dermatology. 2026;25(5):454-459. doi:10.36849/jdd.9192
BibTeX
@article{Nestor2026,
author = {Nestor, Mark S and Chaudry, Aysham and Vanaria, Robert J and Bhupalam, Vishnu},
title = {Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {5},
pages = {454--459},
doi = {10.36849/jdd.9192}
}
EUVIMED